Literature DB >> 2012249

Metabolic and hemodynamic responses to endogenous and exogenous catecholamines in formerly obese subjects.

R L Leibel1, E M Berry, J Hirsch.   

Abstract

Formerly or reduced-obese (RO) subjects exhibit diminished systemic energy requirements for weight maintenance. Based on studies in animals and humans, there is reason to believe that the autonomic nervous system (ANS) plays an important role in coordinate regulation of energy metabolism and may be altered in the RO state. We have, therefore, investigated aspects of autonomic physiology in obese (OB), RO, and never obese (NO) subjects subjected to insulin-mediated hypoglycemia and incremental intravenous infusions of epinephrine. Total catecholamine secretion during insulin-induced hypoglycemia was significantly lower in the RO. The RO showed increased sensitivity to in vivo lipolytic and cardiovascular effects of endogenous and infused catecholamines. In these studies, OB subjects responded more like the NO subjects than did the RO. The RO display characteristic changes in autonomic status that may play a role in their enhanced energy efficiency.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 2012249     DOI: 10.1152/ajpregu.1991.260.4.R785

Source DB:  PubMed          Journal:  Am J Physiol        ISSN: 0002-9513


  3 in total

Review 1.  Catecholamines and obesity: effects of exercise and training.

Authors:  Hassane Zouhal; Sophie Lemoine-Morel; Marie-Eve Mathieu; Gretchen A Casazza; Georges Jabbour
Journal:  Sports Med       Date:  2013-07       Impact factor: 11.136

2.  Lipolytic catecholamine resistance due to decreased beta 2-adrenoceptor expression in fat cells.

Authors:  F Lönnqvist; H Wahrenberg; L Hellström; S Reynisdottir; P Arner
Journal:  J Clin Invest       Date:  1992-12       Impact factor: 14.808

3.  Reducing Adiposity in a Critical Developmental Window Has Lasting Benefits in Mice.

Authors:  Jaclyn S Lerea; Laurence E Ring; Rim Hassouna; Angie C N Chong; Klara Szigeti-Buck; Tamas L Horvath; Lori M Zeltser
Journal:  Endocrinology       Date:  2015-11-20       Impact factor: 4.736

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.